Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study
SEXCHECK - Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study
Candiolo Cancer Institute - IRCCS
150 participants
May 1, 2023
OBSERVATIONAL
Conditions
Summary
Primary objectives: * To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy. * To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life. Secondary objectives: * To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens. * Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.
Eligibility
Inclusion Criteria4
- women aged ≥18 and ≤ 55
- who underwent surgery for early stage breast cancer
- taking endocrine therapy for at least 3 months
- providing an informed consent and completing the study questionnaires.
Exclusion Criteria1
- withdrawal of the informed consent, at any time
Interventions
none, it's a incidence-prevalence study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06458764